Magnetic iron oxide nanoparticles (MNPs) have been under intense investigation for at least
the last five decades as they show enormous potential for many biomedical applications …

Tens of millions of contrast-enhanced magnetic resonance imaging (MRI) exams are
performed annually around the world. The contrast agents, which improve diagnostic …

Iron oxide nanoparticles (IONPs) have emerged as a promising alternative to conventional
contrast agents (CAs) for magnetic resonance imaging (MRI). They have been extensively …

Cancer is one of the most deadly diseases threatening the lives of humans. Although many
treatment methods have been developed to tackle cancer, each modality of cancer treatment …

Iron oxide nanoparticles (IONPs) have been extensively used during the last two decades,
either as effective bio-imaging contrast agents or as carriers of biomolecules such as drugs …

(5aR, 11bS)-4, 5, 5a, 6, 7, 11b-Hexahydro-2-propyl-3-thia-5-azacyclopent-1-ena [c]
phenanthrene-9, 10-diol (A-86929): a potent and selective dopamine D1 agonist that …

Metastasis accounts for the vast majority of cancer deaths. The unique challenges for
treating metastases include their small size, high multiplicity and dispersion to diverse organ …

Owing to their unique physical and chemical properties, magnetic iron oxide nanoparticles
have become a powerful platform in many diverse aspects of biomedicine, including …

In order to translate nanotechnology into medical practice, magnetic nanoparticles (MNPs)
have been presented as a class of non‐invasive nanomaterials for numerous biomedical …

With rapid advances in nanomedicine, magnetic nanoparticles (MNPs) have emerged as a
promising theranostic tool in biomedical applications, including diagnostic imaging, drug …